International Clinical Trial: Dual-valve (Mitral and Tricuspid) Edge-to-Edge Therapy for Severe Mitral Regurgitation with Moderate-or-Greater Tricuspid Regurgitation: A Prospective, Single-Center, Single-Arm Study

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132660) titled 'Dual-valve (Mitral and Tricuspid) Edge-to-Edge Therapy for Severe Mitral Regurgitation with Moderate-or-Greater Tricuspid Regurgitation: A Prospective, Single-Center, Single-Arm Study' on Sept. 17.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

Condition: Mitral regurgitation tricuspid regurgitation heart failure

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: TEER group:115;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/show...